Stockscreener 앱 받기
8.11
1.34%
-0.11
Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스
Ongoing Securities Investigation into Anika Therapeutics, Inc. (ANIK)Contact Levi & Korsinsky - ACCESS Newswire
Applying big data sentiment scoring on Anika Therapeutics Inc.Free Weekly Stock Watch With Growth Focus - Newser
Chart overlay techniques for tracking Anika Therapeutics Inc.3-Day Market Movement Forecast Analysis - Newser
Levi & Korsinsky Launches Fraud Investigation on Behalf of Anika Therapeutics, Inc. (ANIK) Shareholders - ACCESS Newswire
Can Anika Therapeutics Inc. hit a new high this monthShort-Term Trade Setup with Forecast Insight - Newser
Tools to assess Anika Therapeutics Inc.’s risk profileWeekly Market Direction and Sector Summary - Newser
What makes Anika Therapeutics Inc. stock price move sharplyMomentum Entry Alerts with Risk Control - Newser
Applying chart zones and confluence areas to Anika Therapeutics Inc.Free Real-Time Analysis With Entry Targets - Newser
How to manage a losing position in Anika Therapeutics Inc.High Reward Picks with Tight Risk Control - Newser
What’s the recovery path for long term holders of Anika Therapeutics Inc.Risk Managed Watchlist with Breakout Picks - Newser
Anika Therapeutics Inc. stock momentum explainedFree Buy Signal Based on Chart Analysis - Newser
Anika Therapeutics shares rise 2.77% after-hours following positive clinical trial results for Hyalofast. - AInvest
ATTENTION ANIK Shareholders: Lost Money on Anika Therapeutics, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Anika Therapeutics: Undervalued HA Platform with 2027 Catalysts - AInvest
Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts (ANIK) - Seeking Alpha
Anika Therapeutics Inc. stock volume spike explainedFree Investment Strategy With Low Risk - Newser
Published on: 2025-08-06 20:31:06 - Newser
Levi & Korsinsky Investigates Anika Therapeutics, Inc. (ANIK) Over Possible Securities Fraud - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
Anika Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price Following 26% Dive - simplywall.st
Published on: 2025-08-05 23:20:00 - Newser
Combining machine learning predictions for Anika Therapeutics Inc.Free Swing Trading Plan With Smart Signals - Newser
Why Anika Therapeutics Inc. stock attracts strong analyst attentionFree Real Market Momentum Signal Generator - Newser
Anika Therapeutics Under Investigation for Securities Fraud and Misleading Investors. - AInvest
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
What are Anika Therapeutics Inc. company’s key revenue driversUnlock powerful stock screening for profits - Jammu Links News
What catalysts could drive Anika Therapeutics Inc. stock higher in 2025Maximize portfolio growth with strategic plans - Jammu Links News
Should I hold or sell Anika Therapeutics Inc. stock in 2025Exceptional return forecasts - Jammu Links News
When is Anika Therapeutics Inc. stock expected to show significant growthNavigate market volatility with smart strategies - Jammu Links News
How does Anika Therapeutics Inc. compare to its industry peersGet exclusive market analysis for investors - Jammu Links News
What are the latest earnings results for Anika Therapeutics Inc.Build a diversified portfolio for risk management - Jammu Links News
What institutional investors are buying Anika Therapeutics Inc. stockCapitalize on emerging trends for profits - Jammu Links News
Bank of New York Mellon Corp Sells 2,175 Shares of Anika Therapeutics Inc. (NASDAQ:ANIK) - Defense World
Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $15.00 - Defense World
Why is Anika Therapeutics Inc. stock attracting strong analyst attentionMaximize gains with expert trading strategies - Jammu Links News
Anika Therapeutics Q2 2025 Earnings Call: Strong Growth in Regenerative Solutions Revenue Amid Production Challenges and Missed Clinical Trial Endpoints. - AInvest
Kirby McInerney LLP Announces Investigation Against Anika Therapeutics, Inc. (ANIK) on Behalf of Investors - GlobeNewswire
Published on: 2025-08-01 22:12:39 - metal.it
Anika Therapeutics (ANIK) Receives a Buy from B.Riley Financial - The Globe and Mail
Anika Therapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Envestnet Asset Management Inc. Buys 26,557 Shares of Anika Therapeutics Inc. (NASDAQ:ANIK) - Defense World
Anika slumps after trial setback for cartilage repair product - MSN
Anika Therapeutics shares rise 1.30% intraday after reporting considerable above-market revenue growth in H1 2025. - AInvest
Anika (ANIK) Q2 Revenue Beats by 4% - Nasdaq
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2025 Earnings Call Transcript - Insider Monkey
Anika Therapeutics 2025 Q2 Earnings Misses Targets as Net Loss Widens 4411.4% - AInvest
Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Anika Therapeutics Reports Q2 2025 Financial Results - TipRanks
Anika: Q2 Earnings Snapshot - Greenwich Time
Anika Therapeutics’ Earnings Call: A Mixed Outlook - TipRanks
Anika Therapeutics Q2 2025 Earnings: Revenue Beats at $28.2M, EPS Misses at -$0.33. - AInvest
Anika Updates Revenue Guidance Amid Hyalofast Delay; Commercial Channel Growth Now 10%-20% for 2026-2027 - AInvest
0.43%
0.47%
자본화:
|
볼륨(24시간):